These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences. Vaziri ND Kidney Int; 2016 Jul; 90(1):41-52. PubMed ID: 27165836 [TBL] [Abstract][Full Text] [Related]
27. Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: lipid composition and reactivity in vitro. Glomset JA; Norum KR; King W J Clin Invest; 1970 Oct; 49(10):1827-37. PubMed ID: 5456796 [TBL] [Abstract][Full Text] [Related]
28. The effects of diuretics and adrenergic-blocking agents on plasma lipids. Rohlfing JJ; Brunzell JD West J Med; 1986 Aug; 145(2):210-8. PubMed ID: 2876554 [TBL] [Abstract][Full Text] [Related]
29. Effects of beta blockers and other antihypertensive drugs on cardiovascular risk. Chobanian AV Am J Cardiol; 1987 May; 59(13):48F-52F. PubMed ID: 2883879 [TBL] [Abstract][Full Text] [Related]
30. The emerging problem of plasma lipid changes during antihypertensive therapy. Johnson BF J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S213-21. PubMed ID: 6177959 [TBL] [Abstract][Full Text] [Related]
31. Alpha-adrenergic blockers: mechanism of action, blood pressure control, and effects of lipoprotein metabolism. Nash DT Clin Cardiol; 1990 Nov; 13(11):764-72. PubMed ID: 1980236 [TBL] [Abstract][Full Text] [Related]
32. The effects of antihypertensive drugs on serum lipids and lipoproteins, I. Diuretics. Ames RP Drugs; 1986 Sep; 32(3):260-78. PubMed ID: 3530704 [TBL] [Abstract][Full Text] [Related]
33. Metabolic considerations in the choice of therapy for the patient with hypertension. Black HR Am Heart J; 1991 Feb; 121(2 Pt 2):707-15. PubMed ID: 1671190 [TBL] [Abstract][Full Text] [Related]
34. In vitro formation of HDL-2 from HDL-3 and triacylglycerol-rich lipoproteins by the action of lecithin:cholesterol acyltransferase and cholesterol ester transfer protein. Zechner R; Dieplinger H; Steyrer E; Groener J; Calvert D; Kostner GM Biochim Biophys Acta; 1987 Mar; 918(1):27-35. PubMed ID: 3828365 [TBL] [Abstract][Full Text] [Related]
35. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats. Stanely Mainzen Prince P; Kannan NK J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661 [TBL] [Abstract][Full Text] [Related]
36. Review: the effects of antihypertensive agents on serum lipids. Madu EC; Reddy RC; Madu AN; Anyaogu C; Harris T; Fraker TD Am J Med Sci; 1996 Aug; 312(2):76-84. PubMed ID: 8701970 [TBL] [Abstract][Full Text] [Related]
37. Secondary causes of hyperlipidemia. Stone NJ Med Clin North Am; 1994 Jan; 78(1):117-41. PubMed ID: 8283927 [TBL] [Abstract][Full Text] [Related]
38. [Effect of anti-hypertensive treatment on plasma lipids and lipoproteins (author's transl)]. Sauvanet JP; Rouffy J Pathol Biol (Paris); 1981 Sep; 29(7):435-40. PubMed ID: 6117048 [TBL] [Abstract][Full Text] [Related]
39. [Effect of anti-hypertensive treatment on plasma lipids and lipoproteins (author's transl)]. Sauvanet JP; Rouffy J Sem Hop; 1982 Mar; 58(9):563-8. PubMed ID: 6121378 [TBL] [Abstract][Full Text] [Related]
40. Antihypertensive treatment and its implications on lipoprotein metabolism of patients in care by a hypertension and diabetes program in Brazil. Martins RD; Alves Rde S; Silva GG; Martins N; Vasconcelos S; Assreuy A; Martins A; Goretti Queiroz M Acta Med Port; 2008; 21(6):567-74. PubMed ID: 19331790 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]